2m 2m 2m 2m 2m 2m 2m
BioQuest (BQST)
OTC
$0.07-$0.002 (-2.94%)
Price as of Apr 27, 2026- $2.0MMarket Cap
- -93.40%1-Year Change
- Shell CompaniesIndustry
BioQuest (BQST)
$0.07-$0.002 (-2.94%)
Annual
Quarterly
04/30/2022 | 04/30/2021 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | |
Total Operating Expenses | 817,920 -62.83% | 2.2M N/A | |
Operating Profit | -817,920 -62.83% | -2.2M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -30,000 -20.29% | -37,638 N/A | |
Interest Income and Expense and Net | -30,000 -20.29% | -37,638 N/A | |
Total Nonoperating Income and Expense | N/A N/A | 37,638 N/A | |
Income before Taxes | -817,920 -62.83% | -2.2M N/A | |
Income Taxes | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -821,022 -64.67% | -2.3M N/A | |
Net Income from Continuing Operations Applicable to Common | -821,022 -64.67% | -2.3M N/A | |
Basic EPS and Net Income | -0.08 -11.11% | -0.09 N/A | |
Diluted EPS and Net Income | -0.08 -11.11% | -0.09 N/A | |
Basic Weighted Average Shares | 10.1M +22.41% | 8.3M N/A | |
Diluted Weighted Average Shares | 10.1M +22.41% | 8.3M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 33,540 +12,800.00% | 260 N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 33,540 +12,800.00% | 260 N/A | |
Total Current Assets | 33,540 +96.17% | 17,097 N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | |
Total Long-Term Assets | N/A N/A | N/A N/A | |
Total Assets | 33,540 +96.17% | 17,097 N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | 183,300 +358.25% | 40,000 N/A | |
Total Current Liabilities | 466,530 -73.89% | 1.8M N/A | |
Total Long-Term Debt | 30,800 N/A | N/A N/A | |
Total Long-Term Liabilities | 30,800 -77.77% | 138,555 N/A | |
Total Liabilities | 466,530 -73.89% | 1.8M N/A | |
Retained Earnings | -10.7M +8.34% | -9.8M N/A | |
Total Stockholders Equity | -432,990 -75.53% | -1.8M N/A | |
Total Shares Outstanding | 11.3M +29.55% | 8.7M N/A | |
Cash Flow | |||
Cash from Operating Activities | -116,720 -39.59% | -193,206 N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 150,000 -22.40% | 193,300 N/A | |
Financials Ratio | |||
Gross Margin | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | |
Return on Assets | -3,242.77% N/A | N/A N/A | |
Return on Equity | 74.55% N/A | N/A N/A | |
Revenue Growth | N/A N/A | N/A N/A | |
Current Ratio | 0.07 N/A | N/A N/A | |
Cash Ratio | 0.07 N/A | N/A N/A | |
Debt-to-Equity Ratio | -0.49 N/A | N/A N/A | |
Debt-to-Assets Ratio | 6.38 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow